• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型冠状病毒肺炎相关住院患者的呼吸结局:一项荟萃分析

Respiratory Outcomes in Patients Following COVID-19-Related Hospitalization: A Meta-Analysis.

作者信息

Guo Tao, Jiang Fangfang, Liu Yufei, Zhao Yunpeng, Li Yiran, Wang Yihua

机构信息

Biological Sciences, Faculty of Environmental and Life Sciences, University of Southampton, Southampton, United Kingdom.

Department of Mathematical Sciences, Faculty of Social Sciences, University of Southampton, Southampton, United Kingdom.

出版信息

Front Mol Biosci. 2021 Oct 6;8:750558. doi: 10.3389/fmolb.2021.750558. eCollection 2021.

DOI:10.3389/fmolb.2021.750558
PMID:34692771
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8528387/
Abstract

To determine the respiratory outcomes in patients following COVID-19-related hospitalization. Systematic review and meta-analysis of the literature. Forced vital capacity (FVC, % of predicted): 0-3 months post discharge: 96.1, 95% CI [82.1-110.0]; 3-6 months post discharge: 99.9, 95% CI [84.8, 115.0]; >6 months post discharge: 97.4, 95% CI [76.8-118.0]. Diffusing capacity of the lungs for carbon monoxide (DLCO, % of predicted): 0-3 months post discharge: 83.9, 95% CI [68.9-98.9]; 3-6 months post discharge: 91.2, 95% CI [74.8-107.7]; >6 months post discharge: 97.3, 95% CI [76.7-117.9]. Percentage of patients with FVC less than 80% of predicted: 0-3 months post discharge: 10%, 95% CI [6-14%]; 3-6 months post discharge: 10%, 95% CI [2-18%]; >6 months post discharge: 13%, 95% CI [8-18%]. Percentage of patients with DLCO less than 80% of predicted: 0-3 months post discharge: 48%, 95% CI [41-56%]; 3-6 months post discharge: 33%, 95% CI [23-44%]; >6 months post discharge: 43%, 95% CI [22-65%]. The meta-analysis confirms a high prevalence of persistent lung diffusion impairment in patients following COVID-19-related hospitalization. Routine respiratory follow-up is thus strongly recommended.

摘要

确定新冠病毒感染相关住院患者的呼吸结局。对文献进行系统评价和荟萃分析。用力肺活量(FVC,预测值的百分比):出院后0至3个月:96.1,95%置信区间[82.1 - 110.0];出院后3至6个月:99.9,95%置信区间[84.8,115.0];出院后>6个月:97.4,95%置信区间[76.8 - 118.0]。肺一氧化碳弥散量(DLCO,预测值的百分比):出院后0至3个月:83.9,95%置信区间[68.9 - 98.9];出院后3至6个月:91.2,95%置信区间[74.8 - 107.7];出院后>6个月:97.3,95%置信区间[76.7 - 117.9]。FVC低于预测值80%的患者百分比:出院后0至3个月:10%,95%置信区间[6 - 14%];出院后3至6个月:10%,95%置信区间[2 - 18%];出院后>6个月:13%,95%置信区间[8 - 18%]。DLCO低于预测值80%的患者百分比:出院后0至3个月:48%,95%置信区间[41 - 56%];出院后3至6个月:33%,95%置信区间[23 - 44%];出院后>6个月:43%,95%置信区间[22 - 65%]。荟萃分析证实,新冠病毒感染相关住院患者中持续性肺弥散功能障碍的患病率很高。因此,强烈建议进行常规呼吸随访。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59df/8528387/77825c0cca2a/fmolb-08-750558-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59df/8528387/40027726455d/fmolb-08-750558-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59df/8528387/2959fa42320b/fmolb-08-750558-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59df/8528387/659394529fe3/fmolb-08-750558-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59df/8528387/3b055c6e20c9/fmolb-08-750558-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59df/8528387/a1a48ada7b40/fmolb-08-750558-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59df/8528387/77825c0cca2a/fmolb-08-750558-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59df/8528387/40027726455d/fmolb-08-750558-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59df/8528387/2959fa42320b/fmolb-08-750558-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59df/8528387/659394529fe3/fmolb-08-750558-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59df/8528387/3b055c6e20c9/fmolb-08-750558-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59df/8528387/a1a48ada7b40/fmolb-08-750558-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/59df/8528387/77825c0cca2a/fmolb-08-750558-g006.jpg

相似文献

1
Respiratory Outcomes in Patients Following COVID-19-Related Hospitalization: A Meta-Analysis.新型冠状病毒肺炎相关住院患者的呼吸结局:一项荟萃分析
Front Mol Biosci. 2021 Oct 6;8:750558. doi: 10.3389/fmolb.2021.750558. eCollection 2021.
2
3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study.COVID-19 相关住院患者的 3 个月、6 个月、9 个月和 12 个月呼吸结局:一项前瞻性研究。
Lancet Respir Med. 2021 Jul;9(7):747-754. doi: 10.1016/S2213-2600(21)00174-0. Epub 2021 May 5.
3
Elevated plasma levels of epithelial and endothelial cell markers in COVID-19 survivors with reduced lung diffusing capacity six months after hospital discharge.新冠肺炎幸存者出院 6 个月后肺弥散能力降低,其血浆上皮细胞和内皮细胞标志物水平升高。
Respir Res. 2022 Feb 21;23(1):37. doi: 10.1186/s12931-022-01955-5.
4
Non-traditional pulmonary function tests in risk stratification of anatomic lung resection: a retrospective review.非传统肺功能测试在解剖性肺切除风险分层中的应用:一项回顾性研究
Ther Adv Respir Dis. 2024 Jan-Dec;18:17534666241305954. doi: 10.1177/17534666241305954.
5
Health-related quality of life and radiological and functional lung changes of patients with COVID-19 Pneumonia 3 and 10 months after discharge.COVID-19 肺炎患者出院后 3 个月和 10 个月时的健康相关生活质量和肺部影像学及功能变化。
BMC Pulm Med. 2023 Jun 27;23(1):231. doi: 10.1186/s12890-023-02520-6.
6
A Low Forced Vital Capacity (FVC)/Diffusing Capacity of the Lung for Carbon Monoxide (DLCO) Ratio Increases Clinical Suspicion for Fibrotic Hypersensitivity Pneumonitis (FHP) Over Idiopathic Pulmonary Fibrosis (IPF).低用力肺活量(FVC)/肺一氧化碳弥散量(DLCO)比值增加了临床对纤维化性过敏性肺炎(FHP)而非特发性肺纤维化(IPF)的怀疑。
Cureus. 2024 Nov 4;16(11):e73008. doi: 10.7759/cureus.73008. eCollection 2024 Nov.
7
Respiratory function in patients post-infection by COVID-19: a systematic review and meta-analysis.COVID-19 感染后患者的呼吸功能:系统评价和荟萃分析。
Pulmonology. 2021 Jul-Aug;27(4):328-337. doi: 10.1016/j.pulmoe.2020.10.013. Epub 2020 Nov 25.
8
Impact of admission viral load on respiratory outcomes in hospitalized SARS-CoV-2 infected patients with cancer and without cancer: A 2-, 4- and 6-months follow-up prospective study.在患有和不患有癌症的住院 SARS-CoV-2 感染患者中,入院时病毒载量对呼吸结局的影响:一项 2、4 和 6 个月随访前瞻性研究。
J Infect Public Health. 2023 Aug;16(8):1209-1219. doi: 10.1016/j.jiph.2023.05.030. Epub 2023 May 30.
9
Long-Term Pulmonary Sequelae and Immunological Markers in Patients Recovering from Severe and Critical COVID-19 Pneumonia: A Comprehensive Follow-Up Study.重症和危重症新冠肺炎肺炎康复患者的长期肺部后遗症及免疫标志物:一项综合随访研究
Medicina (Kaunas). 2024 Nov 27;60(12):1954. doi: 10.3390/medicina60121954.
10
The Predictive Role of C-Reactive Protein, Leukocyte Cell Count, and Soluble Urokinase Plasminogen Activator Receptor for Pulmonary Sequelae in Hospitalized COVID-19 Survivors: A Prospective Single-Center Cohort Study.C反应蛋白、白细胞计数和可溶性尿激酶型纤溶酶原激活物受体对住院COVID-19幸存者肺部后遗症的预测作用:一项前瞻性单中心队列研究
J Clin Med. 2025 Mar 4;14(5):1717. doi: 10.3390/jcm14051717.

引用本文的文献

1
Evaluating performance on the Glittre-ADL test in men with long COVID 3 years after a SARS-CoV-2 infection.评估新冠病毒感染3年后患有长期新冠的男性在Glittre-ADL测试中的表现。
J Exerc Sci Fit. 2024 Oct;22(4):271-277. doi: 10.1016/j.jesf.2024.03.010. Epub 2024 Mar 29.
2
Dysregulated bidirectional epithelial-mesenchymal crosstalk: a core determinant of lung fibrosis progression.上皮-间质双向串扰失调:肺纤维化进展的核心决定因素
Chin Med J Pulm Crit Care Med. 2024 Mar;2(1):27-33. doi: 10.1016/j.pccm.2024.02.001.
3
Does COVID-19 impair V̇o in patients with cardiorespiratory disease? Insight from cardiopulmonary responses to maximal exercise pre- and post-illness.

本文引用的文献

1
COVID-19 6 months after hospital discharge: pulmonary function impairment and its heterogeneity.出院后6个月的新型冠状病毒肺炎:肺功能损害及其异质性
ERJ Open Res. 2021 Jul 19;7(3). doi: 10.1183/23120541.00196-2021. eCollection 2021 Jul.
2
3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study.COVID-19 相关住院患者的 3 个月、6 个月、9 个月和 12 个月呼吸结局:一项前瞻性研究。
Lancet Respir Med. 2021 Jul;9(7):747-754. doi: 10.1016/S2213-2600(21)00174-0. Epub 2021 May 5.
3
Impaired diffusing capacity for carbon monoxide is common in critically ill Covid-19 patients at four months post-discharge.
COVID-19 是否会损害心肺疾病患者的 V̇o ?从疾病前后最大运动时心肺反应获得的见解。
J Appl Physiol (1985). 2023 Nov 1;135(5):1146-1156. doi: 10.1152/japplphysiol.00357.2023. Epub 2023 Oct 19.
4
Spontaneous physical functional recovery after hospitalization for COVID-19: insights from a 1 month follow-up and a model to predict poor trajectory.新型冠状病毒肺炎(COVID-19)住院后自发的身体功能恢复:1个月随访的见解及预测不良病程的模型
Front Med (Lausanne). 2023 Jul 20;10:1212678. doi: 10.3389/fmed.2023.1212678. eCollection 2023.
5
Trajectory of Post-COVID Self-Reported Fatigue and Dyspnoea in Individuals Who Had Been Hospitalized by COVID-19: The LONG-COVID-EXP Multicenter Study.因新冠病毒病住院患者的新冠后自我报告疲劳和呼吸困难轨迹:长新冠扩展多中心研究
Biomedicines. 2023 Jun 29;11(7):1863. doi: 10.3390/biomedicines11071863.
6
Multicentre study on the accuracy of lung ultrasound in the diagnosis and monitoring of respiratory sequelae in the medium and long term in patients with COVID-19.关于肺超声在新冠病毒病患者中长期呼吸后遗症诊断和监测准确性的多中心研究
Front Med (Lausanne). 2023 May 25;10:1199666. doi: 10.3389/fmed.2023.1199666. eCollection 2023.
7
Evolution and long‑term respiratory sequelae after severe COVID-19 pneumonia: nitric oxide diffusion measurement value.严重 COVID-19 肺炎后的演变和长期呼吸系统后遗症:一氧化氮扩散测量值。
Respir Res. 2023 Feb 13;24(1):48. doi: 10.1186/s12931-023-02344-2.
8
Low Cardiorespiratory Fitness Post-COVID-19: A Narrative Review.新冠病毒感染后心肺功能低:一项叙述性综述。
Sports Med. 2023 Jan;53(1):51-74. doi: 10.1007/s40279-022-01751-7. Epub 2022 Sep 17.
9
Differences in lung function between major race/ethnicity groups following hospitalization with COVID-19.主要种族/族裔群体在因 COVID-19 住院后的肺功能差异。
Respir Med. 2022 Sep;201:106939. doi: 10.1016/j.rmed.2022.106939. Epub 2022 Aug 7.
10
ESCMID rapid guidelines for assessment and management of long COVID.ESCMID 长新冠评估与管理快速指南。
Clin Microbiol Infect. 2022 Jul;28(7):955-972. doi: 10.1016/j.cmi.2022.02.018. Epub 2022 Feb 17.
出院四个月后,重症新冠患者中一氧化碳弥散能力受损的情况很常见。
Respir Med. 2021 Jun;182:106394. doi: 10.1016/j.rmed.2021.106394. Epub 2021 Apr 15.
4
Pulmonary function and COVID-19.肺功能与新型冠状病毒肺炎
Curr Opin Physiol. 2021 Jun;21:29-35. doi: 10.1016/j.cophys.2021.03.005. Epub 2021 Mar 26.
5
Post-acute COVID-19 syndrome.新冠病毒感染后长期综合征。
Nat Med. 2021 Apr;27(4):601-615. doi: 10.1038/s41591-021-01283-z. Epub 2021 Mar 22.
6
Lung diffusing capacity for nitric oxide and carbon monoxide following mild-to-severe COVID-19.轻度至重度 COVID-19 后一氧化氮和一氧化碳肺弥散量。
Physiol Rep. 2021 Feb;9(4):e14748. doi: 10.14814/phy2.14748.
7
Respiratory and Psychophysical Sequelae Among Patients With COVID-19 Four Months After Hospital Discharge.COVID-19 患者出院后 4 个月的呼吸及精神心理后遗症。
JAMA Netw Open. 2021 Jan 4;4(1):e2036142. doi: 10.1001/jamanetworkopen.2020.36142.
8
Surviving COVID-19 in Bergamo province: a post-acute outpatient re-evaluation.贝加莫省新冠肺炎康复者:急性后期门诊再评估
Epidemiol Infect. 2021 Jan 19;149:e32. doi: 10.1017/S0950268821000145.
9
6-month consequences of COVID-19 in patients discharged from hospital: a cohort study.新冠肺炎出院患者 6 个月的后果:一项队列研究。
Lancet. 2021 Jan 16;397(10270):220-232. doi: 10.1016/S0140-6736(20)32656-8. Epub 2021 Jan 8.
10
Dyspnoea, lung function and CT findings 3 months after hospital admission for COVID-19.COVID-19 住院 3 个月后的呼吸困难、肺功能和 CT 表现。
Eur Respir J. 2021 Apr 29;57(4). doi: 10.1183/13993003.03448-2020. Print 2021 Apr.